Medical Care
Global Circulating Tumor Cells (CTC) Market Research Report 2025
- Sep 09, 25
- ID: 409783
- Pages: 89
- Figures: 82
- Views: 47
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTC).
The Circulating Tumor Cells (CTC) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cells (CTC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells (CTC) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Segment by Type
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Segment by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTC) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Circulating Tumor Cells (CTC) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cells (CTC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells (CTC) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Segment by Type
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Segment by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTC) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ex-Vivo Positive Selection
1.2.3 In-Vivo Positive Selection
1.2.4 Negative Selection
1.2.5 Microchips & Single Spiral Micro Channel
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumorigenesis Research
1.3.3 Emt Biomarkers Development
1.3.4 Cancer Stem Cell Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cells (CTC) Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTC) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cells (CTC) Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cells (CTC) Market Dynamics
2.3.1 Circulating Tumor Cells (CTC) Industry Trends
2.3.2 Circulating Tumor Cells (CTC) Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2020-2025)
3.2 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cells (CTC) Revenue
3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cells (CTC) Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells (CTC), Product and Application
3.7 Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTC) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cells (CTC) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2020-2031)
6.2 North America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2020-2031)
7.2 Europe Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AdnaGen
11.1.1 AdnaGen Company Details
11.1.2 AdnaGen Business Overview
11.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
11.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.1.5 AdnaGen Recent Development
11.2 Apocell
11.2.1 Apocell Company Details
11.2.2 Apocell Business Overview
11.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
11.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.2.5 Apocell Recent Development
11.3 Biocep
11.3.1 Biocep Company Details
11.3.2 Biocep Business Overview
11.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
11.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.3.5 Biocep Recent Development
11.4 Canopus Bioscience
11.4.1 Canopus Bioscience Company Details
11.4.2 Canopus Bioscience Business Overview
11.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
11.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.4.5 Canopus Bioscience Recent Development
11.5 Creatv Microtech
11.5.1 Creatv Microtech Company Details
11.5.2 Creatv Microtech Business Overview
11.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
11.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.5.5 Creatv Microtech Recent Development
11.6 Ikonisys
11.6.1 Ikonisys Company Details
11.6.2 Ikonisys Business Overview
11.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
11.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.6.5 Ikonisys Recent Development
11.7 IV Diagnostics
11.7.1 IV Diagnostics Company Details
11.7.2 IV Diagnostics Business Overview
11.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
11.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.7.5 IV Diagnostics Recent Development
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Details
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
11.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.8.5 Miltenyi Biotech Recent Development
11.9 Nanostring Technologies
11.9.1 Nanostring Technologies Company Details
11.9.2 Nanostring Technologies Business Overview
11.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
11.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.9.5 Nanostring Technologies Recent Development
11.10 Rarecells Diagnostics
11.10.1 Rarecells Diagnostics Company Details
11.10.2 Rarecells Diagnostics Business Overview
11.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
11.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.10.5 Rarecells Diagnostics Recent Development
11.11 Vitatex
11.11.1 Vitatex Company Details
11.11.2 Vitatex Business Overview
11.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
11.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.11.5 Vitatex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ex-Vivo Positive Selection
1.2.3 In-Vivo Positive Selection
1.2.4 Negative Selection
1.2.5 Microchips & Single Spiral Micro Channel
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumorigenesis Research
1.3.3 Emt Biomarkers Development
1.3.4 Cancer Stem Cell Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cells (CTC) Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTC) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cells (CTC) Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cells (CTC) Market Dynamics
2.3.1 Circulating Tumor Cells (CTC) Industry Trends
2.3.2 Circulating Tumor Cells (CTC) Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2020-2025)
3.2 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cells (CTC) Revenue
3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cells (CTC) Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells (CTC), Product and Application
3.7 Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTC) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cells (CTC) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2020-2031)
6.2 North America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2020-2031)
7.2 Europe Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AdnaGen
11.1.1 AdnaGen Company Details
11.1.2 AdnaGen Business Overview
11.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
11.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.1.5 AdnaGen Recent Development
11.2 Apocell
11.2.1 Apocell Company Details
11.2.2 Apocell Business Overview
11.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
11.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.2.5 Apocell Recent Development
11.3 Biocep
11.3.1 Biocep Company Details
11.3.2 Biocep Business Overview
11.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
11.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.3.5 Biocep Recent Development
11.4 Canopus Bioscience
11.4.1 Canopus Bioscience Company Details
11.4.2 Canopus Bioscience Business Overview
11.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
11.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.4.5 Canopus Bioscience Recent Development
11.5 Creatv Microtech
11.5.1 Creatv Microtech Company Details
11.5.2 Creatv Microtech Business Overview
11.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
11.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.5.5 Creatv Microtech Recent Development
11.6 Ikonisys
11.6.1 Ikonisys Company Details
11.6.2 Ikonisys Business Overview
11.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
11.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.6.5 Ikonisys Recent Development
11.7 IV Diagnostics
11.7.1 IV Diagnostics Company Details
11.7.2 IV Diagnostics Business Overview
11.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
11.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.7.5 IV Diagnostics Recent Development
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Details
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
11.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.8.5 Miltenyi Biotech Recent Development
11.9 Nanostring Technologies
11.9.1 Nanostring Technologies Company Details
11.9.2 Nanostring Technologies Business Overview
11.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
11.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.9.5 Nanostring Technologies Recent Development
11.10 Rarecells Diagnostics
11.10.1 Rarecells Diagnostics Company Details
11.10.2 Rarecells Diagnostics Business Overview
11.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
11.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.10.5 Rarecells Diagnostics Recent Development
11.11 Vitatex
11.11.1 Vitatex Company Details
11.11.2 Vitatex Business Overview
11.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
11.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025)
11.11.5 Vitatex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ex-Vivo Positive Selection
Table 3. Key Players of In-Vivo Positive Selection
Table 4. Key Players of Negative Selection
Table 5. Key Players of Microchips & Single Spiral Micro Channel
Table 6. Global Circulating Tumor Cells (CTC) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Circulating Tumor Cells (CTC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Circulating Tumor Cells (CTC) Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTC) Market Share by Region (2020-2025)
Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Circulating Tumor Cells (CTC) Market Share by Region (2026-2031)
Table 12. Circulating Tumor Cells (CTC) Market Trends
Table 13. Circulating Tumor Cells (CTC) Market Drivers
Table 14. Circulating Tumor Cells (CTC) Market Challenges
Table 15. Circulating Tumor Cells (CTC) Market Restraints
Table 16. Global Circulating Tumor Cells (CTC) Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Circulating Tumor Cells (CTC) Market Share by Players (2020-2025)
Table 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2024)
Table 19. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Circulating Tumor Cells (CTC), Headquarters and Area Served
Table 22. Global Key Players of Circulating Tumor Cells (CTC), Product and Application
Table 23. Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2020-2025)
Table 27. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2026-2031)
Table 29. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2020-2025)
Table 31. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2026-2031)
Table 33. North America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cells (CTC) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 48. AdnaGen Company Details
Table 49. AdnaGen Business Overview
Table 50. AdnaGen Circulating Tumor Cells (CTC) Product
Table 51. AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 52. AdnaGen Recent Development
Table 53. Apocell Company Details
Table 54. Apocell Business Overview
Table 55. Apocell Circulating Tumor Cells (CTC) Product
Table 56. Apocell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 57. Apocell Recent Development
Table 58. Biocep Company Details
Table 59. Biocep Business Overview
Table 60. Biocep Circulating Tumor Cells (CTC) Product
Table 61. Biocep Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 62. Biocep Recent Development
Table 63. Canopus Bioscience Company Details
Table 64. Canopus Bioscience Business Overview
Table 65. Canopus Bioscience Circulating Tumor Cells (CTC) Product
Table 66. Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 67. Canopus Bioscience Recent Development
Table 68. Creatv Microtech Company Details
Table 69. Creatv Microtech Business Overview
Table 70. Creatv Microtech Circulating Tumor Cells (CTC) Product
Table 71. Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 72. Creatv Microtech Recent Development
Table 73. Ikonisys Company Details
Table 74. Ikonisys Business Overview
Table 75. Ikonisys Circulating Tumor Cells (CTC) Product
Table 76. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 77. Ikonisys Recent Development
Table 78. IV Diagnostics Company Details
Table 79. IV Diagnostics Business Overview
Table 80. IV Diagnostics Circulating Tumor Cells (CTC) Product
Table 81. IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 82. IV Diagnostics Recent Development
Table 83. Miltenyi Biotech Company Details
Table 84. Miltenyi Biotech Business Overview
Table 85. Miltenyi Biotech Circulating Tumor Cells (CTC) Product
Table 86. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 87. Miltenyi Biotech Recent Development
Table 88. Nanostring Technologies Company Details
Table 89. Nanostring Technologies Business Overview
Table 90. Nanostring Technologies Circulating Tumor Cells (CTC) Product
Table 91. Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 92. Nanostring Technologies Recent Development
Table 93. Rarecells Diagnostics Company Details
Table 94. Rarecells Diagnostics Business Overview
Table 95. Rarecells Diagnostics Circulating Tumor Cells (CTC) Product
Table 96. Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 97. Rarecells Diagnostics Recent Development
Table 98. Vitatex Company Details
Table 99. Vitatex Business Overview
Table 100. Vitatex Circulating Tumor Cells (CTC) Product
Table 101. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 102. Vitatex Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Circulating Tumor Cells (CTC) Picture
Figure 2. Global Circulating Tumor Cells (CTC) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Tumor Cells (CTC) Market Share by Type: 2024 VS 2031
Figure 4. Ex-Vivo Positive Selection Features
Figure 5. In-Vivo Positive Selection Features
Figure 6. Negative Selection Features
Figure 7. Microchips & Single Spiral Micro Channel Features
Figure 8. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Circulating Tumor Cells (CTC) Market Share by Application: 2024 VS 2031
Figure 10. Tumorigenesis Research Case Studies
Figure 11. Emt Biomarkers Development Case Studies
Figure 12. Cancer Stem Cell Research Case Studies
Figure 13. Others Case Studies
Figure 14. Circulating Tumor Cells (CTC) Report Years Considered
Figure 15. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Circulating Tumor Cells (CTC) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Circulating Tumor Cells (CTC) Market Share by Region: 2024 VS 2031
Figure 18. Global Circulating Tumor Cells (CTC) Market Share by Players in 2024
Figure 19. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2024
Figure 21. North America Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 23. United States Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 27. Germany Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Region (2020-2031)
Figure 35. China Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 43. Mexico Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 47. Turkey Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 51. Apocell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 52. Biocep Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 53. Canopus Bioscience Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 54. Creatv Microtech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 55. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 56. IV Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 57. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 58. Nanostring Technologies Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 59. Rarecells Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 60. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ex-Vivo Positive Selection
Table 3. Key Players of In-Vivo Positive Selection
Table 4. Key Players of Negative Selection
Table 5. Key Players of Microchips & Single Spiral Micro Channel
Table 6. Global Circulating Tumor Cells (CTC) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Circulating Tumor Cells (CTC) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Circulating Tumor Cells (CTC) Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTC) Market Share by Region (2020-2025)
Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Circulating Tumor Cells (CTC) Market Share by Region (2026-2031)
Table 12. Circulating Tumor Cells (CTC) Market Trends
Table 13. Circulating Tumor Cells (CTC) Market Drivers
Table 14. Circulating Tumor Cells (CTC) Market Challenges
Table 15. Circulating Tumor Cells (CTC) Market Restraints
Table 16. Global Circulating Tumor Cells (CTC) Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Circulating Tumor Cells (CTC) Market Share by Players (2020-2025)
Table 18. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2024)
Table 19. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Circulating Tumor Cells (CTC), Headquarters and Area Served
Table 22. Global Key Players of Circulating Tumor Cells (CTC), Product and Application
Table 23. Global Key Players of Circulating Tumor Cells (CTC), Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Circulating Tumor Cells (CTC) Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2020-2025)
Table 27. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2026-2031)
Table 29. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2020-2025)
Table 31. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2026-2031)
Table 33. North America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cells (CTC) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2026-2031) & (US$ Million)
Table 48. AdnaGen Company Details
Table 49. AdnaGen Business Overview
Table 50. AdnaGen Circulating Tumor Cells (CTC) Product
Table 51. AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 52. AdnaGen Recent Development
Table 53. Apocell Company Details
Table 54. Apocell Business Overview
Table 55. Apocell Circulating Tumor Cells (CTC) Product
Table 56. Apocell Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 57. Apocell Recent Development
Table 58. Biocep Company Details
Table 59. Biocep Business Overview
Table 60. Biocep Circulating Tumor Cells (CTC) Product
Table 61. Biocep Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 62. Biocep Recent Development
Table 63. Canopus Bioscience Company Details
Table 64. Canopus Bioscience Business Overview
Table 65. Canopus Bioscience Circulating Tumor Cells (CTC) Product
Table 66. Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 67. Canopus Bioscience Recent Development
Table 68. Creatv Microtech Company Details
Table 69. Creatv Microtech Business Overview
Table 70. Creatv Microtech Circulating Tumor Cells (CTC) Product
Table 71. Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 72. Creatv Microtech Recent Development
Table 73. Ikonisys Company Details
Table 74. Ikonisys Business Overview
Table 75. Ikonisys Circulating Tumor Cells (CTC) Product
Table 76. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 77. Ikonisys Recent Development
Table 78. IV Diagnostics Company Details
Table 79. IV Diagnostics Business Overview
Table 80. IV Diagnostics Circulating Tumor Cells (CTC) Product
Table 81. IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 82. IV Diagnostics Recent Development
Table 83. Miltenyi Biotech Company Details
Table 84. Miltenyi Biotech Business Overview
Table 85. Miltenyi Biotech Circulating Tumor Cells (CTC) Product
Table 86. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 87. Miltenyi Biotech Recent Development
Table 88. Nanostring Technologies Company Details
Table 89. Nanostring Technologies Business Overview
Table 90. Nanostring Technologies Circulating Tumor Cells (CTC) Product
Table 91. Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 92. Nanostring Technologies Recent Development
Table 93. Rarecells Diagnostics Company Details
Table 94. Rarecells Diagnostics Business Overview
Table 95. Rarecells Diagnostics Circulating Tumor Cells (CTC) Product
Table 96. Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 97. Rarecells Diagnostics Recent Development
Table 98. Vitatex Company Details
Table 99. Vitatex Business Overview
Table 100. Vitatex Circulating Tumor Cells (CTC) Product
Table 101. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2020-2025) & (US$ Million)
Table 102. Vitatex Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Circulating Tumor Cells (CTC) Picture
Figure 2. Global Circulating Tumor Cells (CTC) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Tumor Cells (CTC) Market Share by Type: 2024 VS 2031
Figure 4. Ex-Vivo Positive Selection Features
Figure 5. In-Vivo Positive Selection Features
Figure 6. Negative Selection Features
Figure 7. Microchips & Single Spiral Micro Channel Features
Figure 8. Global Circulating Tumor Cells (CTC) Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Circulating Tumor Cells (CTC) Market Share by Application: 2024 VS 2031
Figure 10. Tumorigenesis Research Case Studies
Figure 11. Emt Biomarkers Development Case Studies
Figure 12. Cancer Stem Cell Research Case Studies
Figure 13. Others Case Studies
Figure 14. Circulating Tumor Cells (CTC) Report Years Considered
Figure 15. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Circulating Tumor Cells (CTC) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Circulating Tumor Cells (CTC) Market Share by Region: 2024 VS 2031
Figure 18. Global Circulating Tumor Cells (CTC) Market Share by Players in 2024
Figure 19. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2024
Figure 21. North America Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 23. United States Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 27. Germany Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Region (2020-2031)
Figure 35. China Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 43. Mexico Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Country (2020-2031)
Figure 47. Turkey Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Circulating Tumor Cells (CTC) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 51. Apocell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 52. Biocep Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 53. Canopus Bioscience Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 54. Creatv Microtech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 55. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 56. IV Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 57. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 58. Nanostring Technologies Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 59. Rarecells Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 60. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232